Biblio Discovery — Demo Discovery Service

2 results for "Mark Heipel"

Showing 1–2 · 0.49 seconds · RSS

  1. Journal Article Full text

    Interleukin-21 Enhances Rituximab Activity in a Cynomolgus Monkey Model of B Cell Depletion and in Mouse B Cell Lymphoma Models

    Cecile M. Krejsa; Rick D. Holly; Mark Heipel et al.

    PLoS ONE, Vol. 8 No. 6 · 2013 · English · PLOS Scopus

    Rituximab, a monoclonal antibody targeting CD20 on B cells, is currently used to treat many subtypes of B cell lymphomas. However, treatment is not curative and response rates are variable. Recombinant interleukin-21 (rIL-21) is a cytokine that enhances immune effector function and affects both…

    Also available at: DOAJ